. Bautista-Hernández I, et al.Molecules. 2021 Aug 25;26(17):5156. doi: 10.3390/molecules26175156.Molecules. 2021.PMID: 34500592
. Thompson MG, et al.N Engl J Med. 2021 Sep 8:NEJMoa2110362. doi: 10.1056/NEJMoa2110362. Online ahead of print.N Engl J Med. 2021.PMID: 34496194
. Schoenfeld AJ, et al.Ann Oncol. 2021 Sep 3:S0923-7534(21)04455-0. doi: 10.1016/j.annonc.2021.08.2151. Online ahead of print.Ann Oncol. 2021.PMID: 34487855
.
. Free PMC article.
.
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group.
.
Melanoma-Differentiation-Associated gene 5 protects against nonalcoholic steatohepatitis in mice.
Zhang X, Yang H, Zeng S, Tian S, Hu S, Yang L, Ma T, Liu Z, Wan J, Zhong Y, Li H.
.
The SIC protocol: A seven-step strategy to minimize complications potentially related to the insertion of centrally inserted central catheters.
Brescia F, Pittiruti M, Ostroff M, Spencer TR, Dawson RB.Brescia F, et al.
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
